These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1338 related items for PubMed ID: 17127481
1. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH. Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481 [Abstract] [Full Text] [Related]
2. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W. Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274 [Abstract] [Full Text] [Related]
11. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia. Bellucci S, Michiels JJ. Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614 [Abstract] [Full Text] [Related]
12. Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation. van Genderen PJ, Lucas IS, van Strik R, Vuzevski VD, Prins FJ, van Vliet HH, Michiels JJ. Thromb Haemost; 1996 Sep; 76(3):333-8. PubMed ID: 8883266 [Abstract] [Full Text] [Related]
13. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party. Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279 [Abstract] [Full Text] [Related]
14. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin. van Genderen PJ, Michiels JJ, van Strik R, Lindemans J, van Vliet HH. Thromb Haemost; 1995 Feb; 73(2):210-4. PubMed ID: 7792731 [Abstract] [Full Text] [Related]
15. Bilateral adrenal swelling as a cause of chest, back, and upper abdominal pain in essential thrombocythemia and polycythemia vera is due to microvascular ischemic thrombosis rather than to hemorrhage. Michiels JJ, Berneman Z, Schroyens W, Krestin GP. Ann Hematol; 2002 Dec; 81(12):691-4. PubMed ID: 12483364 [Abstract] [Full Text] [Related]
16. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils. Falanga A, Marchetti M, Barbui T, Smith CW. Semin Hematol; 2005 Oct; 42(4):239-47. PubMed ID: 16210037 [Abstract] [Full Text] [Related]
17. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Tefferi A. Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582 [Abstract] [Full Text] [Related]
18. [What vascular events suggest a myeloproliferative disorder?]. Hachulla E, Rose C, Trillot N, Caulier-Leleu MT, Pasturel-Michon U. J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402 [Abstract] [Full Text] [Related]
19. Neurologic and visual symptoms in essential thrombocythemia: efficacy of low-dose aspirin. Koudstaal PJ, Koudstaal A. Semin Thromb Hemost; 1997 Dec; 23(4):365-70. PubMed ID: 9263353 [Abstract] [Full Text] [Related]